Cariprazine 0.5 mg capsules, hard, Reagila 6 mg hard capsules, Reagila 4.5 mg hard capsules, Reagila 3 mg hard capsules, Reagila 1.5 mg hard capsules
RGH-188-203
Phase 3 small_molecule active
Quick answer
Cariprazine 0.5 mg capsules, hard, Reagila 6 mg hard capsules, Reagila 4.5 mg hard capsules, Reagila 3 mg hard capsules, Reagila 1.5 mg hard capsules for Adolescent patient (13-17 years of age) with Schizophrenia is a Phase 3 program (small_molecule) at Gedeon Richter Plc. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gedeon Richter Plc.
- Indication
- Adolescent patient (13-17 years of age) with Schizophrenia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active